Clinical Trial Update: Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating resmetirom in post-liver transplant patients with metabolic dysfunction-associated steatohepatitis (MASH) is active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatohepatitis

Drugs mentioned

• Resmetirom (resmetirom)

Snippet

Sponsor: Madrigal Pharmaceuticals, Inc. | Conditions: MASH - Metabolic Dysfunction-Associated Steatohepatitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING